Hackensack Meridian Health
Clinical trials sponsored by Hackensack Meridian Health, explained in plain language.
-
New drug combo aims to tackle Hard-to-Treat multiple myeloma
Disease control TerminatedThis phase 2 study tests the drug selinexor combined with one of three other cancer drugs (carfilzomib, daratumumab, or pomalidomide) in 96 adults with multiple myeloma whose disease has worsened despite current treatment. Participants continue on the combination until the cancer…
Phase: PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 23, 2026 12:09 UTC
-
Lyme disease trial withdrawn before it even started
Disease control TerminatedThis study aimed to test whether giving the antibiotic ceftriaxone every 5 days for about 6 weeks could kill the bacteria causing persistent Lyme disease symptoms. It planned to enroll people aged 18-75 with Post-Treatment Lyme Disease Syndrome. However, the trial was withdrawn b…
Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 22, 2026 11:57 UTC
-
New cocktail of 4 drugs shows promise for Hard-to-Treat myeloma
Disease control OngoingThis study tests a combination of four drugs (carfilzomib, lenalidomide, vorinostat, and dexamethasone) in people whose multiple myeloma has returned or stopped responding to prior treatments. The goal is to find a safe dose and see how well the drugs control the cancer. 17 parti…
Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 18, 2026 11:48 UTC
-
New cocktail targets tough lymphoma
Disease control OngoingThis early-phase study tests a combination of three drugs (ibrutinib, lenalidomide, and rituximab) in people with mantle cell lymphoma that has returned or not responded to prior treatment. The main goal is to find the safest dose of this combination by monitoring side effects. U…
Phase: PHASE1 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
Umbilical cord wrap may help men recover faster after prostate cancer surgery
Symptom relief OngoingThis study tests whether placing a cryopreserved umbilical cord allograft around nerves during robotic prostatectomy helps men regain erectile function and bladder control sooner. About 100 men with prostate cancer will be randomly assigned to receive either standard surgery or s…
Phase: PHASE2, PHASE3 • Sponsor: Hackensack Meridian Health • Aim: Symptom relief
Last updated Jun 22, 2026 11:55 UTC
-
New study questions routine breathing support for healthy newborns
Knowledge-focused OngoingThis pilot study looks at whether full-term newborns with mild breathing problems can safely go without a breathing machine called CPAP. About 22 babies born by scheduled C-section will be watched closely for 20 minutes after birth. The goal is to see if they can breathe on their…
Phase: EARLY_PHASE1 • Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:47 UTC
-
Home visitors test new way to support Parents' mental health
Knowledge-focused ENROLLING_BY_INVITATIONThis study explores how to add a mental health program called Mothers and Babies into existing home visiting services for pregnant people and new parents in Iowa and Indiana. Researchers will work with 1,750 home visitors and program recipients to see how well the program is adop…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:07 UTC
-
Study to see if blood flow test predicts leg amputation risk
Knowledge-focused TerminatedThis study aimed to see if a test measuring blood flow in tiny leg vessels could predict whether a leg can be saved in people with severe peripheral artery disease. It was designed for adults with chronic critical limb ischemia who had a procedure to reopen blocked arteries. Howe…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:08 UTC